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PATHOGENESIS  OF  SHIGELLA  DIARRHEA 
VII.  Evidence  for a  Cell  Membrane  Toxin 
Receptor  Involving  fll  --,  4-Linked 
N-Acetyl-D-Glucosamine  Oligomers* 
BY  GERALD  T. KEUSCH$  ASP MARY  JACEWICZ 
(From the Division  of Infectious Diseases, Department  of Medicine, Mount Sinai School of 
Medicine, City University of New York, New York 10029) 
Shigella dysenteriae 1 (Shiga's bacillus) has two virulence characteristics that 
may be important in the pathogenesis of shigellosis in man, namely the capacity 
to invade  intestinal  epithelial  cells  and also to produce a  protein enterotoxin 
active on intestinal  epithelial  cells  (1-3).  Shiga toxin  (ST) ~ is also cytotoxic to 
HeLa  cells  in  monolayer  culture  and we  have  employed  this  as  an  assay for 
investigation of ST activity (4-6). The present study was designed to determine 
whether or not mammalian cells possess a  membrane receptor for Shiga cyto- 
toxin  and  to  characterize  the  nature  of this  receptor.  The  data  suggest  that 
mammalian cells do indeed possess a toxin receptor, and that oligomeric fll-->4- 
linked N-acetyl-D-glucosamine  (D GlcNAc) is in some way involved. 
Materials and Methods 
Toxin  was  prepared  from  S.  dysenteriae  1,  strain  60-R,  as  previously  described  (5).  This 
material  contained enterotoxic  (ileal loop  secretion),  neurotoxic  (mouse  lethal)  and HeLa  cell 
cytotoxic activities. Cytotoxicity, the most sensitive, quantitative, and reproducible assay, shows 
that ST may be separated by isoe|ectric focusing into two cytotoxic fractions, one with isoelectric 
point (pI) 7.25  (also having the enterotoxic and neurotoxic activities) and the other pI 6.1  (6,  7); 
both fractions are neutralized to an equivalent degree by experimental antisera versus crude ST 
and by convalescent human sera from natural and experimental infection (5). The studies reported 
herein were based entirely upon cytotoxicity assay by the quantitative micromethod of Keusch et 
al.  (4).  A  single ST preparation which had not been separated by isoelectric focusing was used 
throughout (5),  and all  subsequent reference  to toxin in this  paper is  to the cytotoxic  activity. 
Toxin binding  was measured indirectly  by means of  a consumption assay for  toxin.  HeLa cell 
monolayers  or  isolated  rat  liver  cell  membranes were  exposed  to  toxin  for  varying  time  periods  and 
conditions, depending on the nature of the experiment.  When HeLa cells  were studied the 
supernatant  medium was aspirated  from monolayers at  the en~ of  the experimental period.  This 
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was immediately inoculated on to fresh HeLa monolayers to determine residual toxicity and assess 
toxin consumed (bound). Medium without toxin incubated over monolayers, as well as the toxin 
before exposure to HeLa cells was similarly inoculated on to fresh monolayers. The preincubated 
monolayers were then washed three times and fed with fresh toxin-free medium to assay toxicity 
of  the cell bound toxin. Cytotoxicity was determined in all monolayers after 20 h at 37°C (4). When 
consumption of toxin by  liver cell membranes was studied the membrane toxin or membrane 
medium mixture was centrifuged after incubation at 40,000 g for 40 min at 4°C to sediment the cell 
membranes.  Residual  toxicity was  again  assayed in  the supernate by  using fresh HeLa  cell 
monolayers. Toxin not exposed to membranes but otherwise treated in identical manner was also 
assayed. Incubation and centrifugation did not alter toxic activity. 
Removal of cytotoxicity from the medium by HeLa monolayers was found only in association 
with evidence of  toxicity to the cell monolayer (vide infra) and was considered  to represent binding 
of toxin to cells. Consumption of toxin from the medium in the presence of liver cell membranes 
was similarly considered to indicate toxin binding. However, these studies do not permit direct 
quantitative assessment  of actual binding of  toxin molecules, which in turn presents a problem for 
expression of the relative extent of binding under the different experimental conditions used in 
this study.  Therefore, we have simply recorded the difference in mortality  (AM)  due to toxin 
incubated  with  cells  or  membranes  compared  to  toxin  incubated  in  the  absence  of cells  or 
membranes. Under the conditions employed with a 50% lethal dose of toxin (TC~o) the usual AM 
observed with either cells or membranes was about 12%; however, by reference to a dose-response 
curve this represents binding of over 90% of the toxin present. 
Toxicity to  HeLa  cells  in  monolayer was  also  taken  to  be the  result  of toxin  binding.  In 
experiments designed to characterize the membrane receptor, HeLa cells were pretreated with 
various enzymes and lectins, or toxin was incubated with potentially competitive inhibitors; a 
decrease in toxicity after treatment was considered as evidence that the treatment was destroying 
or competitively inhibiting the toxin receptor. These data are expressed as percent inhibition of 
binding calculated as: 
1  toxicity (percent M) to treated cells 
t~ ~  ~  ~o ~  ~i-~)  × 100. 
When rat liver cell membranes were studied in similar experiments, percent inhibition of binding 
was calculated in a  similar fashion by using the hM: 
1  toxin uptake (AM) by treated membranes 
tox~n~iA--M~--by~d~s]  x 100. 
Rat liver cell membranes were prepared from freshly excised livers of adult Sprague-Dawley 
rats by the method of Neville (8).  Animals were killed by a  blow to the head and their livers 
quickly  removed and  placed  in  ice  cold 0.25  M  sucrose.  The  tissue  was  trimmed of fat  and 
connective tissue and finely minced before homogenization in a vol of 50 ml of cold 0.25 M sucrose, 
employing a Dounce homogenizer (Kontes Co., Vineland, N. J.) with 15 strokes of a loose pestle 
and 5 strokes of a  tight pestle. The homogenate was filtered through two layers of gauze and 
centrifuged at 600 g  for 10 min. The supernate was then sedimented at 12,000 g  for 30 min at 4°C. 
The resultant supernate was quickly adjusted to 0.1 M NaC1 and 0.2 M MgSO4 and centrifuged at 
40,000 g for 40 min at 4°C. The supernate was decanted and the membranes were resuspended and 
washed twice in 0.05 M Tris-HC1 buffer, pH 7.4,  by centrifugation at 40,000 g. The final washed 
membrane preparation was resuspended in 0.05 M Tris and adjusted to a protein concentration of 2 
mg/ml by using the method of Lowry et al.  (9) with bovine serum albumin as standard. Electron 
microscopy of the  membrane preparations,  kindly performed by  Dr.  Michael Gerber,  showed 
membrane  vesicles of varying  size,  with  virtually  no  intact  mitochondria  or  mitochondrial 
fragments present. 
Crab shell chitin (Sigma Chemical Co., St. Louis, Mo.) was hydrolyzed in acid according to the 
method of Rupley (10). Chitin oligosaccharides were separated on a charcoal-celite column with a 
linear 0-60% ethanol gradient (10). 
Lysozyme activity  was  assayed  by  using  lyophilized Micrococcus  luteus  substrate  (Sigma 
Chemical Co.). M. luteus was suspended in 0.05  M Tris-HC1 buffer, pH 7.4,  at a concentration of 
0.25 mg/ml and adjusted to yield a suspension  with A,~o of  0.7.2 ml of  this suspension was placed in GERALD  T.  KEUSCH  AND  MARY  JACEWICZ  537 
a standard 1-cm cuvette and 6 U of lysozyme was added in a vol of 25 ~1. The contents were mixed 
by inversion and the subsequent change in A46o was monitored with a recording spectrophotometer 
for a period of 10 min. 
The following chemicals and  enzymes were commercially obtained:  neuraminidase  (Vibrio 
cholerae) from Behring Diagnostics, American Hoechst Corp., Somerville, N. J.; phytohaemagglu- 
tinin from Burroughs  Wellcome & Co.,  Greenville, N.  C.; trypsin,  phospholipase A, galactose 
oxidase, fl-galactosidase, lysozyme, hyaluronidase IV, hyaluronidase V, ~-glucuronidase, methyl 
fl-D-galactopyranoside,  methyl  a-D-galactopyranoside,  isopropyl  ~-D-thiogalactopyranoside, 
stachyose, D-galactose-~-D-thiogalactopyranoside,  raffinose, fetuin, thyroglobulin, ovomucoid, No 
acetyl-D-galactosamine,  N-acetyl-D-glucosamine,  methyl  a-D-glucoside,  methyl  B-D-glucoside, 
methyl  a-D-mannoside,  M.  luteus,  and  concanavalin  A  from  Sigma  Chemical  Co.;  pronase, 
phospholipase  C, p-aminophenyl  B-D thiogalactopyranoside,  galactose, galactosamine,  glucosa- 
mine, mannose, mannosamine, and wheat germ agglutinin from Calbiochem, San Diego,  Calif.; 
highly purified wheat germ agglutinin from Pharmacia Fine Chemicals Inc., Piscataway, N. J.; a- 
glucosidase,  fl-glucosidase,  a-mannosidase,  and  ~-glucuronidase  from  Boehringer  Mannheim 
Biochemicals, Indianapolis, Ind.; and bovine fl-lipoprotein (IV-l) and bovine ~-lipoprotein (III-0) 
from ICN Nutritional Biochemicals Div., International Chemical & Nuclear Corp.,  Cleveland, 
Ohio. 
The following reagents were received as gifts: mixed bovine brain gangliosides (Dr.  W. E. van 
Heyningen)  and  purified  crab  shell  chitin  oligosaccharides  from  dimer  (chitobiose)  through 
hexamer (chitohexose)  (Dr. J. W. Rupley). 
Results 
Demonstration of a Toxin Receptor.  Fig.  1 shows results of binding experi- 
ments by using rat liver cell membranes and toxin diluted to 5 TC~o doses/ml. 
Toxin uptake was directly related to membrane protein added (upper left panel) 
and on the basis of these studies further experiments were conducted by using a 
final concentration of membrane protein of 1 mg/ml and 5 TC~o doses oftoxin/ml. 
Under these conditions uptake of toxin was directly related to time and tempera- 
ture of incubation, but inversely related to the ionic strength of the buffer used. 
Preincubation of membranes with toxin, followed by extensive washing, blocked 
uptake of toxin during a second exposure (Fig. 2). Toxin inactivated by heating 
at  90°C  for  30  min  was  far  less  effective in  blocking  toxin  uptake  than  the 
unheated material. 
By using three different cell lines, HeLa, WI-38, and mouse Y-1 adrenal cells, 
toxin binding was found to correlate with observed biological activity (Fig.  3). 
Only the HeLa cell removed toxin from the medium (right panel) concomitant 
with a cytotoxic effect on the monolayer (left panel). The persistence of toxicity 
in the medium overlying the two insensitive cell types was important in validat- 
ing this indirect consumption assay and as evidence for the presence of a  cell 
membrane receptor for Shiga toxin on susceptible cells. 
Characterization of the Receptor.  Three basic approaches were used to char- 
acterize the membrane receptor. These included (a) enzymatic destruction of  the 
receptor,  (b) competitive inhibition  of toxin binding with a  variety of sugars, 
oligosaccharides,  and glycoproteins, and (c) specific receptor blockade by using 
lectins with known binding specificities. 
ENZYMATIC DESTRUCTION OF  THE  RECEPTOR.  Table  I  shows  the  effect  of 
pretreatment  of liver cell membranes  at 37°C for 30 min with eight enzymes. 
Receptor  activity  was  reduced  by  proteolytic  enzymes,  phospholipases,  and 
lysozyme. The effect of trypsin was inhibited completely by ovomucoid, a potent 
inhibitor  of tryptic  activity.  Because of its  enzymic  specificity,  the  effect of 538  PATHOGENESIS  OF  SHIGELLA  DIARRHEA 
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FIG.  1.  Binding  of  Shiga  cytotoxin  by  rat  liver  cell  membranes  as  a  function of the 
quantity of membranes added  (upper left),  time of incubation,  (upper right) incubation 
temperature  (lower left),  and salt concentration  (lower right).  These  experiments were 
done with a final concentration of membrane protein of 1 mg/ml, except when the quantity 
of membrane protein added was being varied, and 5 TC~o doses of toxin/ml. 
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FIG.  2.  Binding of Shiga cytotoxin by rat liver cell membranes preincubated with un- 
heated toxin, heated (90°C,  30 min) toxin, or buffer. Membranes were washed three times 
after preincubation and then studied to  determine their ability to  bind fresh unheated 
toxin. 
lysozyme was particularly interesting. Since lysozyme activity can be inhibited 
by salt,  the effect of increasing NaC1  concentration on both enzyme activity, 
with M.  luteus  substrate,  and  on the  toxin receptor  was  studied.  Rat  liver 
membranes were preincubated with lysozyme in the presence of varying quanti- GERALD  T.  KEUSCH  AI~D  MARY  JACEWICZ  539 
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FIG.  3.  Binding of Shiga cytotoxin by HeLa,  WI-38,  or Y-1  adrenal  cells in monolayer 
culture. Cytotoxicity to the monolayer after varying periods of exposure to toxin is shown in 
the left panel; the horizontal dashed line indicates percent mortality of HeLa monolayers 
exposed for 20 h to Shiga cytotoxin. Residual cytotoxicity (unbound toxin) in the superna- 
tant medium removed from the monolayers after varying time periods is shown in the right 
panel, and presented as percent mortality of HeLa monolayers exposed for 20 h to the toxin 
containing supernates. 
TABLE  I 
Effect of Enzymatic Treatment of Rat Liver Cell Membranes on 
Binding of Shiga Cytotoxin 
Inhibition of 
Enzyme  Activity/tube  binding 
Trypsin 
U  % 
16,000  62 
32,000  100 
Pronase  18  81 
Phospholipase A  0.22  92 
Phospholipase C  0.6  58 
Galactose oxidase  20.0  4 
B-galactosidase  1.2  0 
Neuraminidase  66.0  0 
Lysozyme  5,000.0  100 
ties of NaC1,  followed by thorough washing before addition of toxin (Fig. 4). 
There was a parallel inhibition of lysozyme action on M. luteus substrate and on 
the toxin receptor of the liver membranes by increasing salt concentration. 
Table II shows results of pretreating intact viable HeLa cell monolayers with 
different enzymes on their ability to bind toxin as determined by direct cytotox- 
icity. Each enzyme employed was first titrated to establish the highest concen- 
tration which itself did not cause either cell death or cell detachment from the 
glass during a 30-min incubation at 37°C. Of  the enzymes studied, only lysozyme 
had  a  demonstrable  inhibitory effect on  toxin  binding.  Addition of natural 540 
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FIG.  4.  Effect of NaC1 concentration on lysis of M. luteus by lysozyme (left panel) and on 
binding of Shiga cytotoxin to lysozyme-treated  rat liver cell membranes (right panel). Toxin 
binding  to  untreated  membranes  is  shown  by the  clear bar,  and  to  lysozyme-treated 
membranes by the hatched bars. The molarity of NaC1 in the buffer is indicated along the 
abscissa. 
TABL~  II 
Effect of Enzymatic Pretreatment of HeLa Cells on Binding of 
Shiga Cytotoxin 
Inhibition of 
Enzyme  Activity/monolayer  binding 
u  % 
Hyaluronidase IV  30  5.5 
Hyaluronidase V  30  3.2 
a-glucosidase  0.1  0 
fl-glucosidase  0.08  0.8 
a-mannosidase  0.02  1.3 
Galactose oxidase  0.2  1.1 
/3-glucuronidase  0.4  0 
fl-galactosidase  0.06  0.9 
Neuraminidase  6.6  0 
Lysozyme  5,000  18.7 
substrate, M. luteus, to the enzyme and HeLa monolayers inhibited the effect of 
the enzyme on the HeLa  cell membrane  receptor (Table III). 
These results suggested that  the cell membrane  receptor for ST was a  glyco- 
protein in some way involving a  lysozyme sensitive substrate.  This was further 
investigated  by inhibition experiments. 
COMPETITIVE INmBITIONS.  Table IV shows the effect on ST binding to HeLa 
cells  of  13  glycoproteins,  substituted  sugars,  and  ganglioside,  all  previously GERALD  T.  KEUSCH  AND  MARY  JACEWICZ 
TABLE III 
Inhibition of Lysozyrne Effect on HeLa Cell Binding of Shiga 
Cytotoxin  by M, luteus 
M. luteus added 
Inhibition of binding 
No Lysozyme  Lysozyme,  5,000 U 
mg/ml  % 
0  0  18.7 
1  2.8  14.1 
10  1.0  5.0 
100  2.9  4.5 
541 
TABLE IV 
Effect of Substituted Sugars, Oligosaccharides,  and Glycoproteins on 
Binding of Shiga Cytotoxin  to HeLa Cells 
Inhibition of 
Inhibitor  Concentration 
binding 
mM  % 
Carbohydrates 
p-aminophenyl-~-n-thiogalactopyranoside  200  3.2 
Methyl B-n-galactopyranoside  100  1.0 
Methyl a-n-galactopyranoside  100  1.5 
Isopropyl ~-D-thiogalactopyranoside  100  3.2 
D-galactosyl fl-n-thiogalactopyranoside  100  0 
Stachyose (a-n-Gal-a-n-Gal-a-D-Glu-fl-D-Fru)  30  2.7 
Raffinose (a-D-Gal-a-n-Glu-/]-n-Fru)  50  3.2 
mg/rnl 
Glycoproteins and Ganglioside 
Fetuin  0.5  0 
Thyroglobulin  15.0  0 
Bovine B-lipoprotein (IV-l)  0.1  0 
Bovine fl-lipoprotein (III-0)  1.0  0.2 
Ovomucoid  30.0  0.2 
Ganglioside (mixed bovine brain)  1.0  0 
demonstrated to inhibit the binding of cholera toxin to its receptor on rat liver 
cell membranes  (11).  None of these compounds, nor 10 simple or amino sugars 
(Table V A), or cholera toxin (Fig. 5), competitively inhibited ST binding to the 
HeLa  cell.  In  contrast,  chitin  oligosaccharide  lysozyme substrates  (10)  were 
effective competitive inhibitors  (Table V B). Optimal inhibition was found with 
the trimer N,N',N" triacetyl chitotriose; the tetramer was somewhat less effi- 
cient,  whereas v-GlcNAc and chitohexaose were virtually without effect. 
RECEPTOR BLOCKADE.  TO examine the specificity of these findings we deter- 
mined the effect of three lectins with known structural binding specificities as 
receptor blockers, including phytohemagglutinin  (PHA), concanavalin A  (Con- 
A),  and  wheat  germ  agglutinin  (WGA).  These  lectins  have  been  previously 
shown to have binding affinities for a-linked D-N-acetyl-galactosamine (PHA), 
carbohydrates  containing  a-D-mannopyranosyl,  a-D-glucopyranosyl,  or  fl-D- 
fructofuranosyl  residues at their nonreducing ends (Con A), or N,N',N"-triace- 542  PATHOGENESIS  OF  SHIGELLA  DIARRHEA 
TABLE  V 
Inhibition of  Binding of Shiga Cytotoxin to HeLa Cells: Effect of Simple and 
Aminosugars and Chitin Oligosaccharides 
Inhibition of  Inhibitor  Concentration  binding 
mM  % 
A  Methyl a-D-mannoside  100  0 
Galactose  50  0 
Galactosamine  50  0 
N-acetyl-D-galactosamine  100  2.7 
Methyl ~-D-galactoside  100  0 
Glucosamine  50  2.0 
N-acetyl-D-glucosamine  100  7.5 
Methyl a-D-glucoside  50  1.0 
Methyl /3-D-glucoside  50  2.5 
Mannose  50  0 
B  N,N'-diacetyl chitobiose  1  8.3 
N,N',N".triacetyl chitotriose  1  45.5 
N,N',N",N'-tetraacetyl  chitotetraose  1  40.0 
N,N',N",N',N'"'-pentaacetyl chito-  1  17.2 
pentaose 
N,N',N",N",N'',N .....  -hexaacetyl  I  3.6 
chitohexaose 
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FIG.  5.  Dose-response of Shiga cytotoxin in HeLa cell monolayers in the presence (dark 
bars) or absence (hatched bars) of 5/~g/ml of cholera enterotoxin. 
tyl chitotriose (WGA) (12-14). The effect of pretreatment  of liver cell membranes 
with  these  three  lectins  is shown  in  Table  VI.  Only  WGA  efficiently blocked 
consumption  of ST by the  membranes.  Table  VII shows the  results  of similar 
experiments  by using  intact  HeLa  cell monolayers.  The  maximum  concentra- GERALD  T.  KEUSCH  AND  MARY  JACEWICZ  543 
TABLE  VI 
Lectin Inhibition of  Binding of Shiga Cytotoxin to Rat Liver Cell 
Membranes 
Lectin concentra- 
tion 
Inhibition of toxin binding, % 
Lectin studied 
PHA  Con A  WGA 
~/ml 
0.01  0  3.3  49.0 
0.1  1.6  5.7  84.1 
1.0  7.3  5.7  92.2 
TABLE  VII 
Lectin Inhibition of Binding of Shiga Cytotoxin to HeLa Cell 
Monolayers 
Lectin concentra- 
tion 
Inhibition  of  toxin  binding,  % 
Lectin  studied 
PHA  Con A  WGA 
ug/ml 
0.01  0  0  6.3 
0.05  NT*  0  15.8 
0.1  NT  0.7  22.2 
0.5  NT  0  27.5 
1.0  NT  0  34.9 
5.0  NT  NT  52.6 
10.0  NT  NT  69.5 
* NT, Not tested because of cell agglutination by this concentration of 
lectin. 
tion of lectin tested was limited in these experiments  by agglutination  of the 
HeLa  cells,  particularly  noted  in  the  presence  of PHA.  Again,  only  WGA 
affected toxin uptake. 
Discussion 
These studies indicate that there is a membrane receptor for Shiga cytotoxin 
on HeLa and rat liver cell membranes. Three distinct lines of evidence all point 
to the  presence of an oligomeric  ~1--* 4-1inked  D GlcNAc determinant  in the 
binding site: (a) it is destroyed by lysozyme, (b) it is competitively inhibited by 
the lysozyme substrates N,N',N"-triacetyl  chitotriose and N,N',N",N'-tetrace- 
tyl chitotetraose, and (c) it is blocked by wheat germ lectin, which has binding 
specificity for N,N',N"-triacetyl chitotriose.  With the exception of proteolytic 
enzymes,  which  might  be  expected  to  disrupt  any  glycoprotein  membrane 
receptor,  and  phospholipase  A  and  C,  which  grossly  altered  the  membrane 
preparations used, all other specific enzymes, haptens and lectins tested in this 
study were without effect on the binding of Shiga cytotoxin. 
These  characteristics  of the  Shiga  toxin  receptor are  clearly  distinct  from 
those described for the cholera toxin receptor, a sialidase resistant monosialosyl 
ganglioside,  GM~  (15-18).  Furthermore,  neither  cholera  toxin  nor  ganglioside 
were able to competitively inhibit the binding of Shiga toxin to either HeLa cells 544  PATHOGENESIS  OF  SHIGELLA  DIARRHEA 
or rat liver cell membranes. It has been shown that the binding of cholera toxin 
to  cell surface membrane receptors  activates  adenylate cyclase (AC),  with a 
resultant increase in intracellular cAMP levels (19). Recent evidence indicates 
that Shiga toxin is also able to activate AC in proximal rabbit small intestine 
(20).  If Shiga  toxin  binds  to  jejunal  cells  through  a  chitin  oligosaccharide 
receptor on their surface, it would suggest either that there are at least two 
enterotoxin paths to activation of AC in small bowel, or a common mechanism 
after initial binding. Holmgren and LSnnroth (21) and Bennett et al.  (22) have 
recently proposed  models for cholera toxin  activation of AC  in which initial 
binding of toxin to a  G.~-containing receptor is followed by interaction of the 
active part of  the toxin molecule with a second receptor which actually results in 
stimulation of AC.  Whatever the mechanism, activation of AC is believed to 
lead to secretion of isotonic fluid and therefore the effects of cholera and Shiga 
toxins on the intestine would both be limited by AC activity. Thus there would 
be no additive effects of maximum secretory doses of the two toxins, previously 
observed to be the case by Steinberg et al.  (23). 
On  the  basis  of the  known secretory responsiveness of small intestine to 
topical application of ST (1, 20, 23) and the reported resistance of  rat colon (24), it 
is  reasonable  to  speculate  that  presence  or  absence  of a  cell  surface  toxin 
receptor is involved in this differential susceptibility. The toxin is also cytotoxic 
to some cells in culture, to rabbit ileal epithelial cells, and causes an inflamma- 
tory enteritis in the latter tissue similar to the colitis caused by invading intact 
bacteria in the large bowel (2). Therefore toxin could play a role in the dysentery 
(colitis) phase of clinical shigellosis as well. If  these speculations are indeed true 
it might suggest that the direct role of bacterial invasion in pathogenesis is, in 
essence, to allow development of a microcolony within the intestinal epithelium 
resulting in local  (? intracellular) production of toxin. This hypothesis might 
also explain why Shigella-Escherichia  coli hybrids, which invade but do not 
multiply in the intestinal mucosa, are avirulent (25) since bacterial multiplica- 
tion would be necessary for toxin production. It is necessary to also postulate a 
site-specific  mechanism  mediating  bacterial  penetration  of the  bowel  since 
shigella are known to invade the colon but not the jejunum (26). Thus patho- 
genesis and clinical manifestations of shigellosis may depend on site specific 
localization of surface receptors on small and large intestinal epithelial cells for 
toxin and whole bacteria, and on intrinsic capacity of the infecting organism to 
produce toxin and to penetrate the intestinal mucosa. 
The chitin oligosaccharide membrane receptor on HeLa cells for Shiga cyto- 
toxin described in the present study suggests that affinity chromatography on a 
chitin column may be useful for toxin purification (27), a necessary step in the 
development of more quantitative methods for the study of the binding of toxin 
to its receptor. Affinity chromatography might also shed light on the relation- 
ships  of cytotoxic, enterotoxic,  and  neurotoxic activities in partially purified 
Shiga toxin. We have recently found that both cytotoxicity  and neurotoxicity  are 
retained by chitin oligosaccharides attached to Sepharose 4-B,  and that both 
activities are released by M NaC1  (27; G. T.  Keusch and M. Jacewicz, unpub- 
lished observations). These preliminary studies imply a similar receptor for at 
least these two biologic activities which are found together with enterotoxin in 
the separated pI 7.25 toxin. GERALD  T.  KEUSCH  AND  MARY  JACEWICZ  545 
Summary 
The binding ofShigeUa dysenteriae 1 cytotoxin to HeLa cells in culture and to 
isolated rat liver cell membranes was studied by means of an indirect consump- 
tion assay of  toxicity from the medium, or by determination of  cytotoxicity  to the 
HeLa  cell  monolayer.  Both  liver  cell  membranes  and  HeLa  cells  removed 
toxicity from the medium during incubation, in contrast to WI-38 and Y-1 mouse 
adrenal tumor cells, both of which neither bound nor were affected by the toxin. 
Uptake of  toxin was directly related to concentration of membranes added, time, 
and temperature, and indirectly related to the ionic strength of the buffer used. 
The chemical nature of the membrane receptor was characterized by using 
three principal approaches: (a) enzymatic sensitivity; (b) competitive inhibition 
and  (c)  receptor blockade studies.  The receptor was destroyed by proteolytic 
enzymes, phospholipases (which markedly altered the gross appearance of the 
membrane preparation) and by lysozyme, but not by a variety of other enzymes. 
Of 28 carbohydrate and glycoprotein haptens studied, including cholera toxin 
and ganglioside, only the chitin oligosaccharide lysozyme substrates,  per N- 
acetylated chitotriose, chitotetraose, and chitopentaose were effective competi- 
tive inhibitors. Greatest inhibition was found with the trimer, N,N',N" triacetyl 
chitotriose.  Of three  lectins  studied  as  possible  receptor  blockers,  including 
phytohemagglutinin, concanavalin A,  and  wheat germ  agglutinin,  only the 
latter, which is known to possess specific binding affinity for N,N',N" triacetyl 
chitotriose, was able to block toxin uptake. 
Evidence from all three approaches indicate, therefore, existence of a  glyco- 
protein toxin receptor on mammalian cells, with involvement of oligomeric fll 
--* 4-1inked N-acetyl glucosamine in the receptor. This receptor is clearly distinct 
from the G~I~ ganglioside thought to be involved in the binding of cholera toxin 
to the cell membrane of a variety of cell types susceptible to its action. 
We thank Dr. Elvin A. Kabat for his careful and critical reading of this manuscript and Dr. 
Michael Gerber for electron microscopy  of liver cell membrane preparations. 
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